RISW2026
Back to all people

Weimeng Wang

FDA Center for Drug Evaluation and Research (CDER)
1 appearance in the program

Sessions & presentations

Poster Session I
Presentation: Qualification of WHO Risk Drinking Level Reduction as an Efficacy Endpoint for Alcohol Use Disorder Trials
Posters · Thu, Sep 17 , 5:45 PM
CoAuthor
↑